INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Cash Flow from Operating Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-4.58 Cr | ₹0.53 Cr | ₹2.91 Cr | ₹0.22 Cr | ₹-0.84 Cr |
What is the latest Cash Flow from Operating Activities ratio of INDO US BIOTECH ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹-4.58 Cr |
Mar2023 | ₹0.53 Cr |
Mar2022 | ₹2.91 Cr |
Mar2021 | ₹0.22 Cr |
Mar2020 | ₹-0.84 Cr |
How is Cash Flow from Operating Activities of INDO US BIOTECH Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-4.58 Cr | Negative | |
Mar2023 | ₹0.53 Cr | -81.91 | |
Mar2022 | ₹2.91 Cr | 1,192.44 | |
Mar2021 | ₹0.22 Cr | Positive | |
Mar2020 | ₹-0.84 Cr | - |
Compare Cash Flow from Operating Activities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹351.0 Cr | 3.1% | 13.1% | -25.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,981.1 Cr | -3.9% | -6.6% | -13.6% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,620.0 Cr | -3.2% | -6.3% | -1.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,113.2 Cr | -0.4% | -6.5% | -21.8% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,404.6 Cr | -4.1% | -5.7% | -31.2% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹537.5 Cr | -7% | 5.4% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | 3.1% |
13.1% |
-25.7% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses